DEFA14A: Premier Urges Stockholders to Vote FOR Patient Square Merger

Premier, Inc. reminds stockholders to vote FOR the proposed merger with Patient Square Capital at the upcoming Special Meeting on November 21, 2025, emphasizing the Board's unanimous recommendation.

Summary

• Premier, Inc. is reminding stockholders to vote for the proposed merger with Patient Square Capital.
• The Special Meeting of stockholders is scheduled for November 21, 2025.
• The Board of Directors unanimously recommends voting FOR the Merger and related proposals.
• Failing to vote will have the same effect as a vote against the Merger.
• Stockholders are urged to vote TODAY via the Internet, telephone, or by signing, dating, and returning the enclosed proxy card or voting instruction form.
• Assistance with voting is available by calling Innisfree M&A Incorporated at (877) 750-9501 (toll-free from the U.S. and Canada) or +1 (412) 232-3651 (from other countries).

Sentiment

Score: 7

Explanation: The filing strongly advocates for the merger, with a unanimous board recommendation, indicating a positive internal view on the transaction. However, it also outlines standard but significant risks associated with mergers, which temper the overall sentiment.

Positives

• The Board of Directors unanimously recommends voting FOR the Merger and related proposals, indicating strong internal support for the transaction.

Negatives

• Failing to vote will have the same effect as a vote against the Merger, potentially leading to an unintended outcome for stockholders who do not participate.

Risks

• Inability to consummate the merger within the anticipated time period, or at all, due to reasons such as failure to obtain required regulatory approvals, satisfy other conditions (including stockholder approval), or complete contemplated financing arrangements.
• Adverse effects on the market price of the Company Class A Common Stock due to announcements relating to the merger.
• Disruption from the merger making it more difficult to maintain business and operational relationships, including retaining and hiring key personnel and maintaining relationships with customers, vendors, and other business partners.
• Occurrence of any event, change, or other circumstances that could give rise to the termination of the merger agreement.
• Risks related to disruption of the Company's current plans and operations or the diversion of management's attention from ongoing business operations due to the merger.
• Significant transaction costs associated with the merger.
• Risk of litigation and/or regulatory actions related to the merger or unfavorable results from currently pending litigation and proceedings or litigation and proceedings that could arise in the future.

Future Outlook

Forward-looking statements include expectations regarding the potential benefits of the merger, anticipated growth rates, the Company's plans, objectives, and the anticipated timing of closing the merger. These statements are based on various assumptions and current expectations, and actual events and circumstances may differ.

Management Comments

• "Your Board of Directors unanimously recommends that you vote FOR the Merger and related proposals."
• "On behalf of Premier, Inc., thank you for your support."

Industry Context

This announcement pertains to a proposed merger involving Premier, Inc., a healthcare improvement company, and Patient Square Capital, a healthcare-focused private equity firm. Such a transaction reflects ongoing consolidation and strategic realignments within the healthcare sector, often driven by aims for operational efficiencies, market expansion, or value creation under new ownership structures.

Legal Proceedings

• Risk of litigation and/or regulatory actions related to the merger.
• Risk of unfavorable results from currently pending litigation and proceedings or litigation and proceedings that could arise in the future.

Stakeholder Impact

• Shareholders: Directly impacted by the merger vote, which will determine the company's future ownership and potentially its stock valuation.
• Employees: The merger poses a risk of disruption, potentially making it more difficult to retain and hire key personnel.
• Customers, Vendors, and Other Business Partners: The merger could disrupt existing business and operational relationships, making them harder to maintain.

Next Steps

• Stockholders are required to vote on the proposed merger and related proposals.
• The Special Meeting of stockholders will take place on November 21, 2025.
• The merger's consummation is contingent upon obtaining required regulatory approvals, satisfying other conditions, and completing contemplated financing arrangements.

Key Dates

Recommendation

The Board of Directors unanimously recommends voting FOR the merger, indicating their belief that the transaction is in the best interest of stockholders. This strong endorsement from management suggests a positive outlook for the company's future under the proposed merger with Patient Square Capital, making it a strong buy for investors who support the merger.

Keywords

Premier Inc., Patient Square Capital, Merger, Proxy Statement, Stockholder Vote, Corporate Governance, Healthcare, Special Meeting